Margaret F Keil1. 1. Section on Endocrinology Genetics, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA. keilm@mail.nih.gov
Abstract
CONTEXT: Cushing syndrome (CS) in children is associated with residual impairment in measures of health-related quality of life, even after successful resolution of hypercortisolemia, highlighting the need for early identification of morbidities and improvements in long-term management of these patients. EVIDENCE ACQUISITION AND SYNTHESIS: A PubMed, Scopus, and Web of Science search of articles from 1900 onward identified available studies related to quality of life and complications of pediatric CS as well as important historical articles. This review summarizes studies through November 2012 and highlights recent developments. CONCLUSIONS: A review of the literature identifies significant morbidities associated with CS of pediatric onset, which must not be treated in isolation. CS affects children and adolescents in many ways that are different than adults. Post-treatment challenges for the child or adolescent treated for CS include: optimize growth and pubertal development, normalize body composition, and promote psychological health and cognitive maturation. All these factors impact health-related quality of life, which is an important outcome measure to assess the burden of disease as well as the effect of treatment. Future research efforts are needed to improve management of the physical, psychological, and emotional aspects of this disease in order to diminish the residual impairments experienced by the pediatric CS patient population.
CONTEXT: Cushing syndrome (CS) in children is associated with residual impairment in measures of health-related quality of life, even after successful resolution of hypercortisolemia, highlighting the need for early identification of morbidities and improvements in long-term management of these patients. EVIDENCE ACQUISITION AND SYNTHESIS: A PubMed, Scopus, and Web of Science search of articles from 1900 onward identified available studies related to quality of life and complications of pediatric CS as well as important historical articles. This review summarizes studies through November 2012 and highlights recent developments. CONCLUSIONS: A review of the literature identifies significant morbidities associated with CS of pediatric onset, which must not be treated in isolation. CS affects children and adolescents in many ways that are different than adults. Post-treatment challenges for the child or adolescent treated for CS include: optimize growth and pubertal development, normalize body composition, and promote psychological health and cognitive maturation. All these factors impact health-related quality of life, which is an important outcome measure to assess the burden of disease as well as the effect of treatment. Future research efforts are needed to improve management of the physical, psychological, and emotional aspects of this disease in order to diminish the residual impairments experienced by the pediatric CS patient population.
Authors: S Scommegna; J P Greening; H L Storr; K M Davies; N J Shaw; J P Monson; A B Grossman; M O Savage Journal: J Endocrinol Invest Date: 2005-03 Impact factor: 4.256
Authors: Dalia Batista; Nickolas A Courkoutsakis; Edward H Oldfield; Kurt J Griffin; Meg Keil; Nickolas J Patronas; Constantine A Stratakis Journal: J Clin Endocrinol Metab Date: 2005-06-07 Impact factor: 5.958
Authors: Deborah P Merke; Jay N Giedd; Margaret F Keil; Sarah L Mehlinger; E A Wiggs; Stuart Holzer; Erin Rawson; A Catherine Vaituzis; Constantine A Stratakis; George P Chrousos Journal: J Clin Endocrinol Metab Date: 2005-03-01 Impact factor: 5.958
Authors: Françoise S Maheu; Luigi Mazzone; Deborah P Merke; Margaret F Keil; Constantine A Stratakis; Daniel S Pine; Monique Ernst Journal: Dev Psychopathol Date: 2008
Authors: Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin Journal: J Clin Endocrinol Metab Date: 2015-07-29 Impact factor: 5.958
Authors: Sara K Bartz; Lefkothea P Karaviti; Mary L Brandt; Monica E Lopez; Prakash Masand; Sridevi Devaraj; John Hicks; Lauren Anderson; Maya Lodish; Meg Keil; Constantine A Stratakis Journal: Int J Pediatr Endocrinol Date: 2015-08-26